Device Medical Device

Fleet Management

Payments companies reported to CMS as associated with Fleet Management. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$3,597associated payments (2023-2025)
74clinicians with associated payments
1company reporting

By year

2025 $3,597

Payments reported as associated with Fleet Management, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Clinical Cardiac Electrophysiology $1,553
Thoracic Surgery (Cardiothoracic Vascular Surgery) $849
Cardiovascular Disease $477
Internal Medicine $147
Family $128
Interventional Cardiology $80.92

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Fleet Management

These are the largest totals companies reported as associated with Fleet Management. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Dinesh Sharma Naples, FL Clinical Cardiac Electrophysiology $494.23
Thomas Callahan Cleveland, OH Clinical Cardiac Electrophysiology $233.82
Rogerio Carrillo Hialeah, FL Thoracic Surgery (Cardiothoracic Vascular Surgery) $194.63
Arjun Mehta Chicago, IL Clinical Cardiac Electrophysiology $146.57
Hugh Vangelder Tavares, FL Thoracic Surgery (Cardiothoracic Vascular Surgery) $133.24
Rohit Mehta Charlotte, NC Cardiovascular Disease $113.25
John Andriulli Camden, NJ Cardiovascular Disease $113.25
Sean Pokorney Morganton, NC Cardiovascular Disease $113.25
Bryon Tompkins Miami, FL Thoracic Surgery (Cardiothoracic Vascular Surgery) $111.65
Christian Cignoni Clearwater, FL Thoracic Surgery (Cardiothoracic Vascular Surgery) $108.58

Prescribed Fleet Management?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.